Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

Evidence

Alzheimers Res Ther. 2024 Jul 10;16(1):159. doi: 10.1186/s13195-024-01507-7.

NO ABSTRACT

PMID:38987826 | DOI:10.1186/s13195-024-01507-7

Document this CPD Copy URL Button

Google

Google Keep

LinkedIn Share Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D Evidence

Cool Evidence: Engaging Young People and Students in Real-World Evidence

Real-Time Evidence Search [Psychiatry]

AI Research

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI RAISR 4D System Psychiatry + Mental Health